Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lavenne-Pardonge

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Acta Cardiologica|January 1, 1975
[Prognosis and treatment of bacterial endocarditis. Review of 70 cases]E Lavenne-Pardonge, C H Chalant, F Lavenne
Thrombosis Research|November 1, 1996
Acquired activated protein C resistance in pregnancyA F Schlit, C Col-De Beys, M Moriau, et al.
Drugs|January 1, 1987
Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre studyJ Renkin, C C Beys, E Lavenne-Pardonge, et al.
The American Journal of Cardiology|May 1, 1987
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplastyC Hanet, M F Rousseau, M F Vincent, et al.
Arzneimittel-Forschung|February 1, 1993
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjectsM Moriau, L Crasborn, E Lavenne-Pardonge, et al.
Thrombosis Research|June 15, 1995
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulantsM Moriau, E Lavenne-Pardonge, L Crasborn, et al.
Arzneimittel-Forschung|May 1, 1993
Treatment of the Raynaud's phenomenon with piracetamM Moriau, E Lavenne-Pardonge, L Crasborn, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 1, 1986
The lupus anticoagulantM Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Thrombosis Research. Supplement|January 1, 1990
A novel preservation medium protecting prostacyclin production and endothelial integrity of the human saphenous vein graftR Dion, E Lavenne-Pardonge, J M Scheiff, et al.
American Heart Journal|July 1, 1985
Propylene glycol-induced heparin resistance during nitroglycerin infusionJ Col, C Col-Debeys, E Lavenne-Pardonge, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Acta Cardiologica|January 1, 1975
[Prognosis and treatment of bacterial endocarditis. Review of 70 cases]E Lavenne-Pardonge, C H Chalant, F Lavenne
Thrombosis Research|November 1, 1996
Acquired activated protein C resistance in pregnancyA F Schlit, C Col-De Beys, M Moriau, et al.
Drugs|January 1, 1987
Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre studyJ Renkin, C C Beys, E Lavenne-Pardonge, et al.
The American Journal of Cardiology|May 1, 1987
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplastyC Hanet, M F Rousseau, M F Vincent, et al.
Arzneimittel-Forschung|February 1, 1993
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjectsM Moriau, L Crasborn, E Lavenne-Pardonge, et al.
Thrombosis Research|June 15, 1995
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulantsM Moriau, E Lavenne-Pardonge, L Crasborn, et al.
Arzneimittel-Forschung|May 1, 1993
Treatment of the Raynaud's phenomenon with piracetamM Moriau, E Lavenne-Pardonge, L Crasborn, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 1, 1986
The lupus anticoagulantM Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Thrombosis Research. Supplement|January 1, 1990
A novel preservation medium protecting prostacyclin production and endothelial integrity of the human saphenous vein graftR Dion, E Lavenne-Pardonge, J M Scheiff, et al.
American Heart Journal|July 1, 1985
Propylene glycol-induced heparin resistance during nitroglycerin infusionJ Col, C Col-Debeys, E Lavenne-Pardonge, et al.
Pageof 2